Name | IRF5-IN-1 |
---|
Description | IRF5-IN-1 (compound C5) is an IRF5 pathway-specific inhibitor. IRF5-IN-1 significantly reduces IRF5 nuclear translocation without affecting the activation of NF-κB p65. IRF5-IN-1 acts through SLC15A4 to selectively inhibit TLR7/8-induced IRF5 responses in cells[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C27H33N3O2 |
---|---|
Molecular Weight | 431.57 |